Cart 0
Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer

Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer

Posted by Corey Marcath on

Single Donor Human Whole Blood from Innovative Research was used in the following study:

 

Scattered DUSP28 is a novel biomarker responsible for aggravating malignancy via the autocrine and paracrine signaling in metastatic pancreatic cancer

Jungwhoi Lee, Jungsul Lee, Jae-Hoon Kim

Cancer Letters
1 March 2019

“…Pancreatic cancer remains one of the most dangerous cancers with a grave prognosis. We have reported that dual specificity phosphatise 28 (DUSP28) could be secreted in pancreatic cancer cells. . …To measure scattered DUSP28 in whole blood of pancreatic cancer patients, blood samples (ten from pancreatic cancer patients and sixteen from healthy individuals) were purchased from Innovative Research (Novi, MI, USA)…”

 

Related products available from Innovative Research also include:

  • Tags: Human Whole Blood, Single Donor Human Whole Blood 

      • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!

    Related Posts

    Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
    In the ever-evolving landscape of molecular biology, precision tools are essential for ...
    Read the Article
    Revolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
    In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
    Read the Article
    Pioneering Advances in Complement-Mediated Disorders: An In-depth Look at SAR443809
    In the dynamic landscape of medical research, SAR443809 emerges as a promising candidat...
    Read the Article

    ← Older Post Newer Post →

    ×